Skip to content

Bayer Halts Roundup Talks After U.S. Supreme Court Inquiry

    
Photographer: Jasper Juinen/Bloomberg

Bayer AG said it’s halting discussions to settle further claims over its Roundup weedkiller after the U.S. Supreme Court signaled interest in the company’s effort to end thousands of suits alleging the product causes cancer.

Bayer is “encouraged” by the court’s call to hear the views of the Solicitor General on its case challenging a $25 million award to Edwin Hardeman, a California man who says decades of exposure to Roundup caused his non-Hodgkin’s lymphoma, the Leverkusen, Germany-based company said in a statement on Monday.